Propolypeptide of von Willebrand factor circulates in blood and is identical to von Willebrand antigen II. 1986

P J Fay, and Y Kawai, and D D Wagner, and D Ginsburg, and D Bonthron, and B M Ohlsson-Wilhelm, and S I Chavin, and G N Abraham, and R I Handin, and S H Orkin

The generally mild bleeding disorder of von Willebrand disease is associated with abnormalities of two distinct plasma proteins, the large multimeric von Willebrand factor (vWF), which mediates platelet adhesion, and von Willebrand antigen II (vW AgII), which is of unknown function. The two proteins were found to have a common biosynthetic origin in endothelial cells and megakaryocytes, which explains their simultaneous absence in the severe form of this hereditary disease. Shared amino acid sequences from a 100-kilodalton plasma glycoprotein and from vW AgII are identical to amino acid sequences predicted from a complementary DNA clone encoding the 5' end of vWF. In addition, these proteins have identical molecular weights and immunologic cross reactivities. Monoclonal antibodies prepared against both proteins recognize epitopes on the pro-vWF subunit and on a 100-kilodalton protein that are not present on the mature vWF subunit in endothelial cell lysates. In contrast, polyclonal antibodies against vWF recognize both pro-vWF and vWF subunits. Thus, the 100-kilodalton plasma glycoprotein and vW AgII are identical proteins and represent an extremely large propolypeptide that is first cleaved from pro-vWF during intracellular processing and then released into plasma.

UI MeSH Term Description Entries
D008970 Molecular Weight The sum of the weight of all the atoms in a molecule. Molecular Weights,Weight, Molecular,Weights, Molecular
D010446 Peptide Fragments Partial proteins formed by partial hydrolysis of complete proteins or generated through PROTEIN ENGINEERING techniques. Peptide Fragment,Fragment, Peptide,Fragments, Peptide
D011498 Protein Precursors Precursors, Protein
D011499 Protein Processing, Post-Translational Any of various enzymatically catalyzed post-translational modifications of PEPTIDES or PROTEINS in the cell of origin. These modifications include carboxylation; HYDROXYLATION; ACETYLATION; PHOSPHORYLATION; METHYLATION; GLYCOSYLATION; ubiquitination; oxidation; proteolysis; and crosslinking and result in changes in molecular weight and electrophoretic motility. Amino Acid Modification, Post-Translational,Post-Translational Modification,Post-Translational Protein Modification,Posttranslational Modification,Protein Modification, Post-Translational,Amino Acid Modification, Posttranslational,Post-Translational Amino Acid Modification,Post-Translational Modifications,Post-Translational Protein Processing,Posttranslational Amino Acid Modification,Posttranslational Modifications,Posttranslational Protein Processing,Protein Processing, Post Translational,Protein Processing, Posttranslational,Amino Acid Modification, Post Translational,Modification, Post-Translational,Modification, Post-Translational Protein,Modification, Posttranslational,Modifications, Post-Translational,Modifications, Post-Translational Protein,Modifications, Posttranslational,Post Translational Amino Acid Modification,Post Translational Modification,Post Translational Modifications,Post Translational Protein Modification,Post Translational Protein Processing,Post-Translational Protein Modifications,Processing, Post-Translational Protein,Processing, Posttranslational Protein,Protein Modification, Post Translational,Protein Modifications, Post-Translational
D001798 Blood Proteins Proteins that are present in blood serum, including SERUM ALBUMIN; BLOOD COAGULATION FACTORS; and many other types of proteins. Blood Protein,Plasma Protein,Plasma Proteins,Serum Protein,Serum Proteins,Protein, Blood,Protein, Plasma,Protein, Serum,Proteins, Blood,Proteins, Plasma,Proteins, Serum
D004727 Endothelium A layer of epithelium that lines the heart, blood vessels (ENDOTHELIUM, VASCULAR), lymph vessels (ENDOTHELIUM, LYMPHATIC), and the serous cavities of the body. Endotheliums
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000595 Amino Acid Sequence The order of amino acids as they occur in a polypeptide chain. This is referred to as the primary structure of proteins. It is of fundamental importance in determining PROTEIN CONFORMATION. Protein Structure, Primary,Amino Acid Sequences,Sequence, Amino Acid,Sequences, Amino Acid,Primary Protein Structure,Primary Protein Structures,Protein Structures, Primary,Structure, Primary Protein,Structures, Primary Protein
D000941 Antigens Substances that are recognized by the immune system and induce an immune reaction. Antigen
D014841 von Willebrand Factor A high-molecular-weight plasma protein, produced by endothelial cells and megakaryocytes, that is part of the factor VIII/von Willebrand factor complex. The von Willebrand factor has receptors for collagen, platelets, and ristocetin activity as well as the immunologically distinct antigenic determinants. It functions in adhesion of platelets to collagen and hemostatic plug formation. The prolonged bleeding time in VON WILLEBRAND DISEASES is due to the deficiency of this factor. Factor VIII-Related Antigen,Factor VIIIR-Ag,Factor VIIIR-RCo,Plasma Factor VIII Complex,Ristocetin Cofactor,Ristocetin-Willebrand Factor,von Willebrand Protein,Factor VIII Related Antigen,Factor VIIIR Ag,Factor VIIIR RCo,Ristocetin Willebrand Factor

Related Publications

P J Fay, and Y Kawai, and D D Wagner, and D Ginsburg, and D Bonthron, and B M Ohlsson-Wilhelm, and S I Chavin, and G N Abraham, and R I Handin, and S H Orkin
June 1989, The Journal of biological chemistry,
P J Fay, and Y Kawai, and D D Wagner, and D Ginsburg, and D Bonthron, and B M Ohlsson-Wilhelm, and S I Chavin, and G N Abraham, and R I Handin, and S H Orkin
April 1987, Proceedings of the National Academy of Sciences of the United States of America,
P J Fay, and Y Kawai, and D D Wagner, and D Ginsburg, and D Bonthron, and B M Ohlsson-Wilhelm, and S I Chavin, and G N Abraham, and R I Handin, and S H Orkin
April 1985, The Journal of clinical investigation,
P J Fay, and Y Kawai, and D D Wagner, and D Ginsburg, and D Bonthron, and B M Ohlsson-Wilhelm, and S I Chavin, and G N Abraham, and R I Handin, and S H Orkin
March 1997, The Journal of biological chemistry,
P J Fay, and Y Kawai, and D D Wagner, and D Ginsburg, and D Bonthron, and B M Ohlsson-Wilhelm, and S I Chavin, and G N Abraham, and R I Handin, and S H Orkin
January 1991, Cell,
P J Fay, and Y Kawai, and D D Wagner, and D Ginsburg, and D Bonthron, and B M Ohlsson-Wilhelm, and S I Chavin, and G N Abraham, and R I Handin, and S H Orkin
March 1991, The Journal of biological chemistry,
P J Fay, and Y Kawai, and D D Wagner, and D Ginsburg, and D Bonthron, and B M Ohlsson-Wilhelm, and S I Chavin, and G N Abraham, and R I Handin, and S H Orkin
June 1993, The Journal of biological chemistry,
P J Fay, and Y Kawai, and D D Wagner, and D Ginsburg, and D Bonthron, and B M Ohlsson-Wilhelm, and S I Chavin, and G N Abraham, and R I Handin, and S H Orkin
May 1991, Biochemical and biophysical research communications,
P J Fay, and Y Kawai, and D D Wagner, and D Ginsburg, and D Bonthron, and B M Ohlsson-Wilhelm, and S I Chavin, and G N Abraham, and R I Handin, and S H Orkin
April 1989, The Journal of biological chemistry,
P J Fay, and Y Kawai, and D D Wagner, and D Ginsburg, and D Bonthron, and B M Ohlsson-Wilhelm, and S I Chavin, and G N Abraham, and R I Handin, and S H Orkin
April 1998, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis,
Copied contents to your clipboard!